India, Aug. 5 -- Corbus Pharmaceuticals Holdings, Inc. (CRBP), a U.S.-based pharmaceutical company, reported a wider loss in the second quarter.
The company reported a net loss of $17.7 million or $1.44 per share in the second quarter of 2025, compared to a net loss of $10 million or $0.90 per share.
The rise in losses during this quarter was caused by increased operating expenses, particularly driven by higher clinical development expenses.
Tuesday, CRBP closed at $8.90, down 4.71%, and is trading flat after hours on the NasdaqCM.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....